← Leaderboards
Xiaomei Ma
Yale University
$8,166,960
Attributed
$15,505,706
Total exposure
12
Grants
5
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $2.1M · FY2006–25$2.5M$1.9M$1.3M$625K$0
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$15,505,706 · 12
By mechanism
R01$11,212,781 · 4
T32$1,979,324 · 2
R21$1,280,239 · 3
K07$687,338 · 1
P30$178,524 · 1
R03$167,500 · 1
Top collaborators
- Joseph Leo Wiemels14 shared
- Melinda L Irwin6 shared
- Yongtao Guan4 shared
- Catherine Metayer3 shared
- Andrew Dewan2 shared
- Nicole Deziel1 shared
- Krystal Pollitt1 shared
Most similar at Yale University
Same institution · by research overlap
- Craig M Crews$33,790,660
- Dustin Scheinost$8,044,506
- Nicole Deziel$3,662,571
- Krystal Pollitt$443,853
Others in their field
Top investigators on “Risk Factors”
- Jeffrey P Krischer · University Of South Florida$393,499,152
- Mitchell J Malone · Texas A&M Research Foundation$320,373,312
- Gary D Acton · University Of California-Davis$320,373,312
- Chanza Baytop · Westat, Inc.$271,217,917
- Richard Webby · St. Jude Children'S Research Hospital$180,330,417
- John M Lachin · George Washington University$139,236,598
Research focus
Risk FactorsMalignant NeoplasmsAffectEtiologyLeukemiaBaseIncidencePatternExposure ToLinkArchivesChildCharacteristicsPopulation BasedPublishingDiagnosisBirthCancer TypeInfectionNeonatalImmune SystemPregnancyCase ControlAccounting
Grant awards (38)
Cytomegalovirus as an etiologic and clinico-pathogenic factor in childhood acute lymphoblastic leukemia$676,777
R01 · FY2025 · CA
The Yale Cancer Prevention and Control Training Program$472,462
T32 · FY2025 · CA
Early-life exposures to extreme weather-related factors and pediatric thyroid cancer risk$431,386
R21 · FY2025 · CA
Using targeted and non-targeted approaches to examine per- and polyfluoroalkyl substances (PFAS) exposure and glioma risk in young children$431,377
R21 · FY2025 · CA · contact PI
Cancer Prevention & Control Research Program$97,007
P30 · FY2025 · CA · contact PI
Cytomegalovirus as an etiologic and clinico-pathogenic factor in childhood acute lymphoblastic leukemia$322,911
R01 · FY2024 · CA
The Yale Cancer Prevention and Control Training Program$307,095
T32 · FY2024 · CA
Cancer Prevention & Control Research Program$81,517
P30 · FY2024 · CA · contact PI
Cytomegalovirus as an etiologic and clinico-pathogenic factor in childhood acute lymphoblastic leukemia$667,990
R01 · FY2023 · CA
The Yale Cancer Prevention and Control Training Program$286,870
T32 · FY2023 · CA
Cytomegalovirus as an etiologic and clinico-pathogenic factor in childhood acute lymphoblastic leukemia$703,419
R01 · FY2022 · CA
The Yale Cancer Prevention and Control Training Program$276,987
T32 · FY2022 · CA
The Yale Cancer Prevention and Control Training Program$265,119
T32 · FY2021 · CA
The Yale Cancer Prevention and Control Training Program$261,141
T32 · FY2020 · CA
Perinatal immune development and risk of childhood acute lymphoblastic leukemia$445,030
R01 · FY2018 · CA
Identification of microRNA variants associated with acute lymphoblastic leukemia$83,750
R03 · FY2018 · CA
Perinatal immune development and risk of childhood acute lymphoblastic leukemia$346,914
R01 · FY2017 · CA
Perinatal immune development and risk of childhood acute lymphoblastic leukemia$328,290
R01 · FY2017 · CA
Identification of microRNA variants associated with acute lymphoblastic leukemia$83,750
R03 · FY2017 · CA
Perinatal immune development and risk of childhood acute lymphoblastic leukemia$618,506
R01 · FY2016 · CA
New Statistical Methods to Handle Spatial Uncertainty in Cancer Risk Estimation$442,893
R01 · FY2016 · CA
Perinatal immune development and risk of childhood acute lymphoblastic leukemia$625,049
R01 · FY2015 · CA
New Statistical Methods to Handle Spatial Uncertainty in Cancer Risk Estimation$439,012
R01 · FY2015 · CA
Genome-Wide Association Study of Childhood Leukemia by Hispanic Status$725,965
R01 · FY2014 · CA
Perinatal immune development and risk of childhood acute lymphoblastic leukemia$670,671
R01 · FY2014 · CA
New Statistical Methods to Handle Spatial Uncertainty in Cancer Risk Estimation$397,769
R01 · FY2014 · CA
Genome-Wide Association Study of Childhood Leukemia by Hispanic Status$1,561,623
R01 · FY2013 · CA
New Statistical Methods to Handle Spatial Uncertainty in Cancer Risk Estimation$448,311
R01 · FY2013 · CA
Genome-Wide Association Study of Childhood Leukemia by Hispanic Status$225,573
R01 · FY2012 · CA
Yale/NCI Cooperative Training Program in Cancer Epidemiology$109,650
T32 · FY2012 · CA · contact PI
Genome-Wide Association Study of Childhood Leukemia by Hispanic Status$1,566,078
R01 · FY2011 · CA
Myelodysplastic Syndromes: Patterns of Care and Outcomes$221,532
R21 · FY2010 · CA · contact PI
Myelodysplastic Syndromes: Previous Exposures, Survival, and Quality of Life$135,186
K07 · FY2010 · CA · contact PI
Myelodysplastic Syndromes: Patterns of Care and Outcomes$195,944
R21 · FY2009 · CA · contact PI
Myelodysplastic Syndromes: Previous Exposures, Survival, and Quality of Life$132,192
K07 · FY2009 · CA · contact PI
Myelodysplastic Syndromes: Previous Exposures, Survival, and Quality of Life$139,588
K07 · FY2008 · CA · contact PI
Myelodysplastic Syndromes: Previous Exposures, Survival, and Quality of Life$140,186
K07 · FY2007 · CA · contact PI
Myelodysplastic Syndromes: Previous Exposures, Survival, and Quality of Life$140,186
K07 · FY2006 · CA · contact PI